Clinical Trial Search

Primary: Percentage of Participants Who Appropriately Self-selected DR-104 (Plan B® 1.5) When Dispensed Under Simulated Over-the-counter (OTC) Conditions — 90.1 percentage of…

Primary: Pregnancy Rate at One-month — 1.96 percentage of participants

Primary: Maximum Serum Concentration Between Normal and Obese BMI Women Ingesting 1.5mg Levonorgestrel — 10.3; 5.57 ng/mL

Primary: Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception — 9; 13 participants

Primary: Percentage of Pregnancies Prevented (PPP) — 77.5; 36.9 percentage of pregnancies prevented — p=<0.0001

Primary: Number of Participants With Pregnancy Following Emergency Contraception — 0; 0; 0; 6 Participants

Primary: The Number of Participants in Two Treatment Groups (1.5mg Levonorgestrel and 3mg Levonorgestrel) With no Follicle Rupture at 5 Days Within One Menstrual (Treatment)…

Primary: Self-reported Uptake of Effective Ongoing Contraception (Not Condoms) — 5; 13; 22; 0 participants — p=<0.001

Primary: Percentage of Pregnancies Prevented — 94.7; 63.3 percentage of pregnancies prevented — p=<0.0001

Primary: Pregnancy Rate — 2.1 percentage of participants

Primary: Proportion of Dosing Instances Among User Population Taken Within 120 Hours (5 Days) of Most Recent Episode of Unprotected Sex. — 704 Dosing instances 120 hrs of…

Primary: Number of Participants With Pregnancy — 20; 30 Participants

Primary: Percentage of Participants Reporting a Pregnancy — 0; 0.3 % of participants reporting pregnancy

Primary: Number of Participants With Delay in Follicular Rupture Beyond 5 Days — 46; 43; 12 Participants

Primary: ABILITY TO FOLLOW POSTPARTUM TEENS FOR 1 YEAR. — 22; 16 Participants

Primary: Number of Participants With Follicle Rupture — 1; 9 Participants

Primary: Length of Stay — 287 minutes

Primary: Efficacy: the Pearl Index (Number of Pregnancies Per 100 Woman-years) in the Primary Evaluable Population (18-35) — 22.4 pregnancies per 100 woman years

Primary: Intention to Initiate Contraception — 59 Participants

Primary: Area Under the Curve From Time 0 to 24 Hours of Serum LNG Concentration — 208.5; 100.8 ng*h/mL — p=<0.01

Primary: Adolescent Feasibility of Intervention — 4.5; 4.7 score on a scale

Primary: Number of Participants Who Experienced Assessed Pregnancy Outcomes — 1; 0; 1; 0 Participants

Primary: Number of Participants With Ovulation With Implant-alone — 7; 0 Participants

Primary: Potential Efficacy: Effective Contraception Initiation Rates [Time Frame: Enrollment, 12 Weeks Post-enrollment (2 Weeks Post Close of Intervention)] — 14; 14 Participants

Primary: LNG Area Under the Concentration-time Curve (AUC0-8h) Calculated Based on Intensive LNG PK Samples Obtained From Individual Participants — 52.13; 102.13; 80.50; 124.39…

Primary: Pregnancy Rate (Expressed as Pearl Index) for Women 18 to 45 Years Old, MITT Population — 1.823; 2.978 Pearl Index

Primary: Number of Participants With Implant Continuation — 219; 225 Participants

Primary: Continuation Rates — 82; 78; 83 participants

Primary: The Number of On-treatment Pregnancies (With + 7-day Window) Per 100 Woman-years of Exposure (Pearl Index) in Subjects Aged 16 to 35 Years, Inclusive, at the Time of…

Primary: Contraceptive Acceptability and Use of Contraceptives During the 6-month Follow-up — 121; 86 participants